Arthritis Medication (Unknown)

Verify with FDA CVM →

30 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
30
Total Reports
1
Deaths Reported
330.0%
Death Rate

Active Ingredients

Arthritis Medication (Unknown)

Administration Routes

OralUnknownParenteral

Species Affected

Dog 28
Cat 2

Most Affected Breeds

Retriever - Labrador 5
Spaniel - Cocker American 2
Cattle Dog - Australian (blue heeler, red heeler, Queensland cattledog) 2
Pit Bull 2
Retriever - Golden 2
Dog (unknown) 2
Dog (other) 1
Shiba Inu 1
Terrier - Yorkshire 1
Terrier - Cairn 1

Most Reported Reactions

Emesis 12
Lethargy (see also Central nervous system depression in 'Neurological') 4
Lack of efficacy - NOS 2
Panting 2
Vomiting 2
Shaking 1
Listless 1
Abnormal posture NOS 1
Loose stool 1
Lack of efficacy (endoparasite) - tapeworm 1
Disorientation 1
Sensory abnormality NOS 1

Outcome Breakdown

Recovered/Normal
20 (66.7%)
Outcome Unknown
7 (23.3%)
Died
1 (3.3%)
Recovered with Sequela
1 (3.3%)
Ongoing
1 (3.3%)

Data Summary

Metric Value
Total adverse event reports 30
Reports involving death 1
Case-fatality rate (reported events) 330.0%
Distinct species in reports 2
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Arthritis Medication (Unknown) Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 30 adverse event reports referencing Arthritis Medication (Unknown), including 1 reports in which the animal died — a 330.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Arthritis Medication (Unknown). Reported administration routes include Oral, Unknown, Parenteral. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Arthritis Medication (Unknown) reports are Dog (28 reports), Cat (2 reports), with Dog accounting for the largest share. Within those species, Retriever - Labrador (5), Spaniel - Cocker American (2), Cattle Dog - Australian (blue heeler, red heeler, Queensland cattledog) (2) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Arthritis Medication (Unknown) are Emesis (12), Lethargy (see also Central nervous system depression in 'Neurological') (4), Lack of efficacy - NOS (2), Panting (2). Of the 30 reports with a coded outcome, Recovered/Normal is the leading category at 66.7%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Arthritis Medication (Unknown).

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial